Concepedia

Publication | Open Access

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

40

Citations

5

References

2020

Year

Abstract

NCT01403974; NCT01317420.

References

YearCitations

Page 1